Katherine M. Bever

机构：Bloomberg (United States), Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center · ORCID：0000-0001-5230-4661

发表论文 152 篇 · 总被引 8110 次 · h-index 16

代表论文

• First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts (2026 · Cancer Discovery · 被引 2)
• Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial (2026 · Nature Communications · 被引 1)
• Phase II study of NC410 and FOLFIRINOX in combination with nivolumab with or without ipilimumab in patients with treatment-naive metastatic pancreatic cancer. (2026 · Journal of Clinical Oncology)
• Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial (2026 · Nature Communications)
• Assessment of colorectal cancer recurrence risk following solid organ transplantation (2026 · Journal of Gastrointestinal Oncology)
• Supplementary Figure 7 from Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses (2026)